With the analysis among 787 patents, we discovered top 269 key players by total patent application. Immatics Biotechnologies GmbH, GI Innovation, Inc., Janssen Vaccines & Prevention BV are dominant in this area. They take 14.99% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 50
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 28
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 26
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 23
GlaxoSmithKline Biologicals SA
Kleo Pharmaceuticals, Inc.
Connecticut, United States
Patent: 17
Zhengzhou Houyi Pharmaceutical Co. Ltd.
Henan Sheng, China
Patent: 16
Innate Tumor Immunity, Inc.
New York, United States
Patent: 13
With the analysis among 100 patents, we discovered top 12 start-ups by total patent application. GI Innovation, Inc., Noile-Immune Biotech, Inc., Kleo Pharmaceuticals, Inc. are active in this area.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 23
Kleo Pharmaceuticals, Inc.
Connecticut, United States
Patent: 17
Kumquat Biosciences, Inc.
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 2
California, United States
Patent: 1
Inno Lake Pharmaceutical (Hangzhou) Co., Ltd.
Zhejiang Sheng, China
Patent: 1
With the analysis among related 636 patents applied in the last 5 years. We discover 274 most active companies in this area. The fast-growing GI Innovation, Inc., Noile-Immune Biotech, Inc., Immatics Biotechnologies GmbH take 12.89% of patent filing during this period.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 23
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 19
Kleo Pharmaceuticals, Inc.
Connecticut, United States
Patent: 17
Yamaguchi-ken, Japan
Patent: 14
Innate Tumor Immunity, Inc.
New York, United States
Patent: 13
Korea University Reserch & Business Foundation
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 9
With the analysis among related 636 patents in last 5 years, we discover 243 new entrants. GI Innovation, Inc., Noile-Immune Biotech, Inc., Kleo Pharmaceuticals, Inc. are the most active new entrants in this area.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 23
Kleo Pharmaceuticals, Inc.
Connecticut, United States
Patent: 17
Innate Tumor Immunity, Inc.
New York, United States
Patent: 13
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 9
Research & Business Foundation Sungkyunkwan University
Jiangsu Sheng, China
Patent: 7
With the analysis among 353 patents, we discovered top 99 universities and scientific research institutions by total patent application. Yamaguchi University, University of Washington, Jiangnan University are dominant in this area. They take 12.75% of the total patent filing.
Yamaguchi-ken, Japan
Patent: 23
Washington, United States
Patent: 12
Jiangsu Sheng, China
Patent: 7
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 6
South China Agricultural University
Guangdong Sheng, China
Patent: 6
National Taiwan University
Taiwan Province, China
Patent: 5
Council of Scientific & Industrial Research
Institute of Process Engineering, Chinese Academy of Sciences
Beijing Shi, China
Patent: 4